Get started
Author

José Luis Cuadra‐Urteaga

Observed names: Cuadra Urteaga, José Luis, Cuadra-Urtega, José, J. Cuadra-Urteaga, J.L. Cuadra, J.L. Cuadra Urteaga, J.L. Cuadra Urtega, J.L. Cuadra-Urteaga, Jose Cuadra-Urteaga, Jose Luis Cuadra, Jose Luis Cuadra-Urteaga, Jose Luis Gago, Jose Luis Manzano, José Cuadra, José Cuadra A, José Luis Cuadra, José Luis Cuadra Urteaga, José Luis Cuadra-Urteaga, José Luis Cuadra‑Urteaga, José Luís Cuadra Urteaga
Observed institutions: Universitat Autònoma de Barcelona, Baylor College of Medicine, National University of San Marcos, Texas Oncology, Institut Català d'Oncologia, Hospital Quirónsalud Barcelona, Vall d'Hebron Hospital Universitari, Ministry of Health, Hospital Universitari Germans Trias i Pujol, Vall d'Hebron Institute of Oncology
ORCID: 0000-0002-9495-7318
Observed ORCID: 0000-0002-9495-7318
OpenAlex ID: A5002243695
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
2021 · Javier Ros, Iosune Baraibar, et al. · Therapeutic Advances in Medical Oncology · 70
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
2020 · Giulia Martini, Rodrigo Dienstmann, et al. · Therapeutic Advances in Medical Oncology · 58
Hashimoto's encephalopathy presenting with neurocognitive symptoms: a case report
2010 · Carlos Canelo-Aybar, David Loja-Oropeza, et al. · Journal of Medical Case Reports · 27
PDF
Outcome prognostic factors in inoperable malignant bowel obstruction
2016 · Margarita Romeo, Maria de los LLanos Gil, et al. · Supportive Care in Cancer · 24
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer
2021 · Javier Ros, Iosune Baraibar, et al. · Current Treatment Options in Oncology · 23
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
2022 · Elena Élez, Núria Mulet-Margalef, et al. · International Journal of Molecular Sciences · 14
PDF
Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update
2020 · Iosune Baraibar, Javier Ros, et al. · Expert Review of Molecular Diagnostics · 13
Carcinosarcoma of the upper urinary tract with an aggressive angiosarcoma component
2016 · José Luis Cuadra-Urteaga, Albert Font, et al. · Cancer Biology & Therapy · 12
PDF
Human T Lymphotropic virus-1 associated gastrointestinal histoplasmosis in Peru
2011 · Carlos Canelo-Aybar, Jose Cuadra-Urteaga, et al. · The Journal of Infection in Developing Countries · 12
PDF
Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils
2018 · Nina Anika Richarz, Luis Puig, et al. · Cancer Biology & Therapy · 8
PDF
Up-to-date role of aflibercept in the treatment of colorectal cancer
2021 · Nadia Saoudi Gonzalez, Francesc Salvà, et al. · Expert Opinion on Biological Therapy · 7
Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or triplet targeted therapy.
2020 · Javier Ros Montañá, Giulia Martini, et al. · Journal of Clinical Oncology · 7
Lupus eritematoso sistémico, en un paciente varón: a propósito de un caso
2013 · Franco Romaní, Fernando Atencia, et al. · Anales de la Facultad de Medicina · 4
PDF
[Liver abscess: clinical, imaging and management features in a 5 year study in the Arzobispo Loayza National Hospital].
2010 · Leonidas Carrillo Nañez, José Luis Cuadra Urteaga, et al. · Revista de Gastroenterología del Perú · 3
Endocarditis infecciosa: análisis retrospectivo en el Hospital Nacional Arzobispo Loayza, 2002-2007
2009 · Franco Romaní, José Luis Cuadra‐Urteaga, et al. · Revista Peruana de Epidemiología · 3
Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN).
2015 · Enric Carcereny Costa, Anna Estival, et al. · Journal of Clinical Oncology · 2
374P Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab +/-binimetinib (E-C+/-B)
2022 · F.J. Ros Montana, V. Navarro, et al. · Annals of Oncology · 1
Young-onset colorectal cancer: A call for action.
2021 · Iosune Baraibar, Francesc Salva, et al. · Journal of Clinical Oncology · 1
Rechallenge with Bevacizumab (Bev) in Patients (P) with Glioblastoma (Gbm) and Previous Objective Response to Bev
2014 · A. Indacochea, A. Estival, et al. · Annals of Oncology · 1
Macroglobulinemia de Waldenströn: comunicación de un caso
2013 · Franco Romaní, José Cuadra, et al. · Anales de la Facultad de Medicina · 1
PDF
Fiebre Prolongada Como Manifestación De Aspergiloma Pulmonar En Un Paciente Con Antecedente De Tuberculosis
2008 · Carrillo-Ñañez, Leonidas, Canelo-Aybar, Carlos, et al. · Americanae (AECID Library) · 1
[Tumoral microembolism and cor-pulmonar as manifestation of hepatocelular carcinoma].
2008 · Carlos Gilberto Canelo Aybar, José Luís Cuadra Urteaga, et al. · PubMed · 1
Infectious endocarditis of pulmonary native valve
2007 · Franco Romaní R, Fernando Atencia M, et al. · Revista Peruana de Medicina Experimental y Salud Pública · 1
76P Association of clinicopathological (C-P) features and tumor (tum) immune contexture with dissemination pattern in metastatic colorectal cancer (mCRC)
2024 · F. Salvà Ballabrera, E. Garcia-Galea, et al. · Annals of Oncology
PDF
Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT).
2015 · Jose Luis Manzano, Anna Martinez Cardús, et al. · Journal of Clinical Oncology
Works count: 41
Citation count: 294
H-index: 9
I10-index: 9
Year
Topic
Type